Cosmo Bio Company,Limited

3386.T
Diagnostics & Research
2026/08/05 Updated
Market Cap: $45.4M (¥7.2B)
Stock Price: $8.01 (¥1,263)
Exchange Rate: 1 USD = ¥157.73

Stock Price Chart

2026/08/05 Updated
21.09
PER (Price Earnings Ratio)
vs Industry Avg: +11.5
0.76
PBR (Price to Book Ratio)
vs Industry Avg: -0.5
3.99%
Dividend Yield
vs Industry Avg: +1.04%

Price Trend

2026/08/05 Updated
Short-term
5-Day MA
+0.29%
Near-term
25-Day MA
+0.56%
Mid-term
75-Day MA
+2.65%
Long-term
200-Day MA
+1.01%

Price & Trading Details

2026/08/05 Updated

PRICE

Previous Close ¥1,266
Open ¥1,256
High ¥1,280
Low ¥1,256
Close ¥1,263

TRADING

Volume 3,300
Average Volume 4,430
Turnover ¥4,167,900
Min. Purchase ¥126,300

Shareholder Composition

Updated 2026/08/01
24.7%
Insider Holdings
19.1%
Institutional
56.3%
Public Float
1
Institutional Holders
Insider Holdings 24.7%
Institutional 19.1%
Public Float 56.3%

Dividend History

Updated 2026/08/02
-%
Dividend Yield
¥25
Annual Dividend
-50.0%
YoY Growth
-%
Payout Ratio
Year Dividend Change
2026 ¥25 -50.0%
2025 ¥50 0.0%
2024 ¥50 +66.7%
2023 ¥30 -16.7%
2022 ¥36 -

Financial Performance

2026/08/02 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥9,553M ¥9,340M ¥10,037M ¥10,766M
Gross Profit ¥3,440M ¥3,249M ¥3,329M ¥3,702M
Operating Income ¥816M ¥520M ¥319M ¥343M
Pretax Income ¥790M ¥653M ¥369M ¥504M
Net Income ¥517M ¥442M ¥262M ¥337M
EPS ¥89.13 ¥75.97 ¥45.05 -
Operating Margin 8.54% 5.57% 3.18% 3.19%
Balance Sheet
Total Assets ¥10,313M ¥10,872M ¥11,723M ¥12,662M
Total Equity ¥8,052M ¥8,444M ¥8,966M ¥9,373M
Total Liabilities ¥2,261M ¥2,428M ¥2,757M ¥3,289M
Cash ¥3,036M ¥2,826M ¥2,393M ¥2,747M
Interest-bearing Debt ¥20M ¥20M ¥20M ¥20M
Equity Ratio 78.08% 77.67% 76.48% 74.02%
D/E Ratio 0.00 0.00 0.00 0.00
Cash Flow
Operating CF ¥284M ¥736M ¥241M ¥595M
Investing CF -¥291M -¥758M -¥217M ¥43M
Financing CF -¥236M -¥201M -¥479M -¥283M
Free CF ¥180M ¥636M -¥35M ¥314M
Efficiency
ROE 6.42% 5.23% 2.92% 3.60%
ROA 5.01% 4.07% 2.23% 2.66%

Company Information

English Name Cosmo Bio Company,Limited
Japanese Name コスモ・バイオ(株)
Stock Code 3386.T (JPX)
Sector / Industry Healthcare / Diagnostics & Research
Employees 182

About

Cosmo Bio Company,Limited, together with its subsidiaries, operates as a life science trading company worldwide. It is involved in the import, export, manufacture, marketing, sales, and customer support of life science research bio tools, such as reagents, kits, instruments, and software. The company also distributes antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, and bacteria, as well as detection reagents, cell and tissue culture systems, and gene analysis systems; and research instruments, including electrophoresis apparatuses, cell culture labware, gene manipulation systems, and data analysis software. In addition, it provides drug discovery and custom research services; clinical diagnostics; cell and DNA, and protein engineering solutions; disposable items and general labware; and bioactive substances; consigned services, such as intestinal flora analysis, tear fluid analysis, and cell assays services; and custom peptide synthesis and antibody production services. Further, the company manufactures and sells cell/cell culture products comprising adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem cells, feeder cells, tumor cell lines, macrophage-related, and coating reagents; measurement and staining kits, detection/purification kits related to neurodementia, macrophage/immune, exosome, and anti-saccharification/anti-aging; and biotechnology research equipment, such as constant-temperature transport containers, aluminum block mat heat insulation devices, and dew condensation prevention glass plate. It serves universities, public research institutes, and companies engaged in biological science. Cosmo Bio Company, Limited was founded in 1978 and is headquartered in Koto, Japan.

Data provided by Yahoo Finance